Shawn B. Jones
Eli Lilly (United States)(US)
Publications by Year
Research Areas
Cholinesterase and Neurodegenerative Diseases, Receptor Mechanisms and Signaling, Coordination Chemistry and Organometallics, Neuroscience and Neuropharmacology Research, Analytical chemistry methods development
Most-Cited Works
- → Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease(2003)191 cited
- → Clozapine is a potent and selective muscarinic M4 receptor agonist(1994)190 cited
- → Novel Benzisoxazole Derivatives as Potent and Selective Inhibitors of Acetylcholinesterase(1994)109 cited
- → Pharmacological Characterization of a Potent Inhibitor of Autotaxin in Animal Models of Inflammatory Bowel Disease and Multiple Sclerosis(2016)28 cited
- → ChemInform Abstract: 5,7‐Dihydro‐3‐(2‐(1‐(phenylmethyl)‐4‐piperidinyl)ethyl)‐6H‐pyrrolo(3,2‐ f)‐1,2‐benzisoxazol‐6‐one: A Potent and Centrally‐Selective Inhibitor of Acetylcholinesterase with an Improved Margin of Safety.(1995)3 cited
- → Clozapine is a potent agonist at human m4 muscarinic receptors and an antagonist at m1, m2, m3, & m5 receptors(1995)3 cited
- → ChemInform Abstract: Syntheses and Anticholinesterase Activity of Tetrahydrobenzazepine Carbamates.(1994)1 cited
- → ChemInform Abstract: Syntheses, Resolution, and Structure—Activity Relationships of Potent Acetylcholinesterase Inhibitors: 8‐Carbaphysostigmine Analogues.(1993)1 cited
- UNIQUE SELECTIVITY OF ZIRCHROM COLUMNS IN SEPARATIONS OF POLAR AND NON-POLAR MIXTURES(2004)
- → Discovery of a novel, structurally unique class of muscarinic agonists(1997)